• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ras转化的生物学检测

Biological assays for Ras transformation.

作者信息

Clark G J, Cox A D, Graham S M, Der C J

机构信息

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill 27599, USA.

出版信息

Methods Enzymol. 1995;255:395-412. doi: 10.1016/s0076-6879(95)55042-9.

DOI:10.1016/s0076-6879(95)55042-9
PMID:8524126
Abstract

The rodent fibroblast systems described above have provided sensitive and rapid biological assays to characterize the properties of normal and mutated Ras proteins. Furthermore, these assays have provided in vitro systems to measure the ability of other cellular components to modulate Ras signal transduction and transformation. However, while these assays provide an excellent measure of Ras-transforming activity, the fact that these cells are of fibroblastic origin, and can be transformed by a single hit, indicates that caution should be used in extrapolating observations from NIH 3T3 transformation assays to the situation in human tumors. Therefore, using human epithelial cell-based assays that more closely approximate the cell types where mutated ras alleles are most frequently detected may provide more realistic assays for examining the biochemical and biological consequences of aberrant Ras function in human tumors. Nevertheless, despite these cautions, these rodent transformation assays will continue to be the best and most widely applied assays for Ras biological activity.

摘要

上述啮齿动物成纤维细胞系统提供了灵敏且快速的生物学检测方法,以表征正常和突变型Ras蛋白的特性。此外,这些检测方法还提供了体外系统,用于测量其他细胞成分调节Ras信号转导和转化的能力。然而,尽管这些检测方法能很好地衡量Ras转化活性,但这些细胞起源于成纤维细胞,且只需一次打击就能被转化,这一事实表明,在将NIH 3T3转化检测的观察结果外推至人类肿瘤情况时应谨慎。因此,使用基于人类上皮细胞的检测方法,这些方法更接近最常检测到突变型ras等位基因的细胞类型,可能会为研究异常Ras功能在人类肿瘤中的生化和生物学后果提供更现实的检测方法。尽管如此,尽管有这些注意事项,这些啮齿动物转化检测仍将继续是用于Ras生物学活性的最佳且应用最广泛的检测方法。

相似文献

1
Biological assays for Ras transformation.Ras转化的生物学检测
Methods Enzymol. 1995;255:395-412. doi: 10.1016/s0076-6879(95)55042-9.
2
Biological assays for cellular transformation.
Methods Enzymol. 1994;238:277-94. doi: 10.1016/0076-6879(94)38026-0.
3
Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.Raf-1/丝裂原活化蛋白激酶级联反应的激活不足以使RIE-1上皮细胞发生Ras转化。
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6924-8. doi: 10.1073/pnas.93.14.6924.
4
The role of non-ras transforming genes in chemical carcinogenesis.非Ras转化基因在化学致癌作用中的作用。
Environ Health Perspect. 1991 Jun;93:33-40. doi: 10.1289/ehp.919333.
5
Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.来自c-H-ras癌基因转化的NIH 3T3细胞的隐性(中介体-)回复突变体:裸鼠中的致瘤性以及培养中回收的肿瘤细胞的短暂锚定非依赖性和血清非依赖性
J Cell Physiol. 1991 Nov;149(2):214-21. doi: 10.1002/jcp.1041490207.
6
SCH 51344 inhibits ras transformation by a novel mechanism.SCH 51344通过一种新机制抑制ras转化。
Cancer Res. 1995 Nov 1;55(21):5106-17.
7
Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.EJ/ras在人尿道上皮细胞体外转化不同阶段的肿瘤进展。
Cancer Res. 1992 Feb 1;52(3):688-95.
8
R-Ras promotes tumor growth of cervical epithelial cells.R-Ras促进宫颈上皮细胞的肿瘤生长。
Cancer. 2003 Feb 1;97(3):575-85. doi: 10.1002/cncr.11093.
9
Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.口服生物可利用的法尼基蛋白转移酶抑制剂SCH 59228对癌基因转化的成纤维细胞生长及裸鼠人结肠癌异种移植瘤的影响。
Cancer Chemother Pharmacol. 1999;43(1):50-8. doi: 10.1007/s002800050862.
10
Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.显性负性raf-1突变体的逆转录病毒基因转移可抑制Ha-Ras诱导的转化并延迟肿瘤形成。
Cancer Gene Ther. 2000 May;7(5):697-706. doi: 10.1038/sj.cgt.7700155.

引用本文的文献

1
Transmembrane prostatic acid phosphatase: a therapeutic target in advanced prostate cancer.跨膜前列腺酸性磷酸酶:晚期前列腺癌的一个治疗靶点。
Am J Clin Exp Urol. 2024 Oct 15;12(5):255-265. doi: 10.62347/DZIU5992. eCollection 2024.
2
Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket.用靶向开关 I/II 口袋的泛 RAS 单域抗体抑制 RAS 驱动的信号传导和肿瘤发生。
Proc Natl Acad Sci U S A. 2022 Oct 25;119(43):e2204481119. doi: 10.1073/pnas.2204481119. Epub 2022 Oct 17.
3
Identification of the nucleotide-free state as a therapeutic vulnerability for inhibition of selected oncogenic RAS mutants.
鉴定无核苷酸状态为抑制特定致癌性 RAS 突变体的治疗弱点。
Cell Rep. 2022 Feb 8;38(6):110322. doi: 10.1016/j.celrep.2022.110322.
4
Probing RAS Function with Monobodies.利用单域抗体探究RAS功能。
Methods Mol Biol. 2021;2262:281-302. doi: 10.1007/978-1-0716-1190-6_17.
5
Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis.靶向 KRASα4-α5 变构界面抑制胰腺癌发生。
Small GTPases. 2022 Jan;13(1):114-127. doi: 10.1080/21541248.2021.1906621. Epub 2021 May 5.
6
DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters.DIRAS3(ARHI)通过直接结合 RAS 并破坏 RAS 簇来阻断 RAS/MAPK 信号通路。
Cell Rep. 2019 Dec 10;29(11):3448-3459.e6. doi: 10.1016/j.celrep.2019.11.045.
7
An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation.RHEB 的致癌突变体 RHEB Y35N 与 BRAF 发生改变的相互作用导致癌症转化。
BMC Cancer. 2018 Jan 10;18(1):69. doi: 10.1186/s12885-017-3938-5.
8
A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.β-连环蛋白-TCF4 相互作用的小分子抑制剂在体外和体内抑制结直肠癌的生长。
EBioMedicine. 2017 Nov;25:22-31. doi: 10.1016/j.ebiom.2017.09.029. Epub 2017 Sep 27.
9
Analysis of K-Ras Interactions by Biotin Ligase Tagging.通过生物素连接酶标记分析K-Ras相互作用
Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):225-239. doi: 10.21873/cgp.20034.
10
AMP-activated protein kinase fortifies epithelial tight junctions during energetic stress via its effector GIV/Girdin.AMP激活的蛋白激酶在能量应激期间通过其效应器GIV/Girdin强化上皮紧密连接。
Elife. 2016 Nov 4;5:e20795. doi: 10.7554/eLife.20795.